Novel treatment options for acute hepatic porphyrias-Reference-Cited by-同舟云学术

Novel treatment options for acute hepatic porphyrias

Published:2021-05 Issue:3 Volume:37 Page:194-199
ISSN:0267-1379
Container-title:Current Opinion in Gastroenterology
language:en
Short-container-title:

Author:

Wang Bruce

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference47 articles.

1. Porphyria;Bissell;N Engl J Med,2017

2. Porphyrias;Puy;Lancet,2010

3. Drugs mediate the transcriptional activation of the 5-aminolevulinic acid synthase (ALAS1) gene via the chicken xenobiotic-sensing nuclear receptor (CXR);Fraser;J Biol Chem,2002

4. Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells;Tian;J Biol Chem,2011

5. Translational control of erythroid delta-aminolevulinate synthase in immature human erythroid cells by heme;Smith;Cell Mol Biol (Noisy-le-grand),1997

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comparison of Currently Approved Small Interfering RNA (siRNA) Medications to Alternative Treatments by Costs, Indications, and Medicaid Coverage;Pharmacy;2024-03-28

2. Nanoparticles and siRNA: A new era in therapeutics?;Pharmacological Research;2024-03

3. Clinical features of acute attacks, chronic symptoms, and long-term complications among patients with acute hepatic porphyria in Japan: a real-world claims database study;Orphanet Journal of Rare Diseases;2023-12-08

4. Acute intermittent porphyria complicated with acute pancreatitis: A case report and literature review;Medicine;2023-11-17

5. Portuguese Consensus on Acute Porphyrias: Diagnosis, Treatment, Monitoring and Patient Referral;Acta Médica Portuguesa;2023-11-02